I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Thol, F
136
results:
Search for persons
X
Format
Online (129)
Print (7)
Mediatypes
Books (3)
Articles (Online) (54)
OpenAccess-fulltext (75)
Video (DVD/CD) (4)
Languages
german (8)
english (117)
more...
russian (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:
Kasprzak, A.
;
Strupp, C.
;
Haase, D.
...
Leukemia Research. 128 (2023) - p. 107224 , 2023
Link:
https://doi.org/10.1016/..
?
2
Randomized phase-III study of low-dose cytarabine and etopo..:
Schlenk, R. F.
;
Weber, D.
;
Krzykalla, J.
...
Scientific Reports. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:
Schulz, F.
;
Kellersmann, C.
;
Betz, B.
...
Leukemia Research. 128 (2023) - p. 107225 , 2023
Link:
https://doi.org/10.1016/..
?
4
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogene..:
Bernard, E.
;
Hasserjian, R.
;
Greenberg, P.
...
Leukemia Research. 128 (2023) - p. 107146 , 2023
Link:
https://doi.org/10.1016/..
?
5
P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATI..:
Ruecker, F. G.
;
Corbacioglu, A.
;
Theis, F.
...
HemaSphere. 6 (2022) - p. 348-349 , 2022
Link:
https://doi.org/10.1097/..
?
6
P468: MRD AS A BIOMARKER FOR RESPONSE TO DONOR LYMPHOCYTE I..:
Teich, K.
;
Stadler, M.
;
Gabdoulline, R.
...
HemaSphere. 6 (2022) - p. 367-368 , 2022
Link:
https://doi.org/10.1097/..
?
7
P1024: IMPACT OF TP53 IN MYELOFIBROSIS UNDERGOING STEM CELL..:
Gagelmann, N.
;
Badbaran, A.
;
Panagiota, V.
...
HemaSphere. 6 (2022) - p. 914-915 , 2022
Link:
https://doi.org/10.1097/..
?
8
Was ist gesichert in der Therapie der akuten myeloischen Le..:
Thol, F.
Der Internist. 60 (2019) 12 - p. 1240-1250 , 2019
Link:
https://doi.org/10.1007/..
?
9
Randomized phase-II trial evaluating induction therapy with..:
Schlenk, R. F.
;
Weber, D.
;
Herr, W.
...
Leukemia. 33 (2019) 8 - p. 1923-1933 , 2019
Link:
https://doi.org/10.1038/..
?
10
Incidence and prognostic impact of ASXL2 mutations in adult..:
Jahn, N
;
Agrawal, M
;
Bullinger, L
...
Leukemia. 31 (2017) 4 - p. 1012-1015 , 2017
Link:
https://doi.org/10.1038/..
?
11
DNMT3A mutant transcript levels persist in remission and do..:
for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)
;
Gaidzik, V I
;
Weber, D
...
Leukemia. 32 (2017) 1 - p. 30-37 , 2017
Link:
https://doi.org/10.1038/..
?
12
Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective ag..:
Chaturvedi, A
;
Herbst, L
;
Pusch, S
...
Leukemia. 31 (2017) 10 - p. 2020-2028 , 2017
Link:
https://doi.org/10.1038/..
?
13
Epidemiological, genetic, and clinical characterization by ..:
German-Austrian AML Study Group (AMLSG)
;
Nagel, Gabriele
;
Weber, D.
...
Annals of Hematology. 96 (2017) 12 - p. 1993-2003 , 2017
Link:
https://doi.org/10.1007/..
?
14
Impact of salvage regimens on response and overall survival..:
Wattad, M
;
Weber, D
;
Döhner, K
...
Leukemia. 31 (2017) 6 - p. 1306-1313 , 2017
Link:
https://doi.org/10.1038/..
?
15
Impact of pretreatment characteristics and salvage strategy..:
and for the German-Austrian AMLSG
;
Schlenk, R F
;
Frech, P
...
Leukemia. 31 (2017) 5 - p. 1217-1220 , 2017
Link:
https://doi.org/10.1038/..
1-15